Clinical Trial Update: A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing twice-daily versus once-daily anti-HIV regimens with or without direct observation; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED